Your browser doesn't support javascript.
loading
Specific sequelae symptoms of COVID-19 of Omicron variant in comparison with non-COVID-19 patients: a retrospective cohort study in Japan.
Omori, Takahiro; Hanafusa, Mariko; Kondo, Nobuyuki; Miyazaki, Yasunari; Okada, Shusho; Fujiwara, Takeo; Kuramochi, Jin.
Afiliação
  • Omori T; Department of Respiratory Medicine, Kuramochi Clinic Interpark, Utsunomiya City, Japan.
  • Hanafusa M; Department of Respiratory Medicine, Kuramochi Clinic Interpark, Utsunomiya City, Japan.
  • Kondo N; Department of Tokyo Metropolitan Health Policy Advisement, Tokyo Medical and Dental University, Tokyo, Japan.
  • Miyazaki Y; Department of Respiratory Medicine, Kuramochi Clinic Interpark, Utsunomiya City, Japan.
  • Okada S; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Fujiwara T; Department of Respiratory Medicine, Kuramochi Clinic Interpark, Utsunomiya City, Japan.
  • Kuramochi J; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
J Thorac Dis ; 16(5): 3170-3180, 2024 May 31.
Article em En | MEDLINE | ID: mdl-38883639
ABSTRACT

Background:

The specific long-term sequela of coronavirus disease 2019 (COVID-19), also known as long COVID of the Omicron variant remain unclear, due to a lack of cohort studies that include non-COVID patients with cold-like symptoms. The study was conducted to examine specific sequelae symptoms after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, which is considered the Omicron variant, compared with patients who were never-infected.

Methods:

In this retrospective cohort study, we sent questionnaires in November 2022, targeting those who visited our fever outpatient unit of a single institution from July to September 2022. SARS-CoV-2 infection status was determined by SARS-CoV-2 polymerase chain reaction (PCR) test results during the study period collected in electronic medical records. Clinical characteristics at 30 days or more since the date of SARS-CoV-2 PCR test were assessed by the questionnaires. Multiple logistic regression was performed to investigate the independent association between SARS-CoV-2 infection and possible sequelae symptoms.

Results:

In total, valid responses were received from 4,779 patients (mean age 41.4 years, standard deviation 19.8 years old). Among them, 3,326 (69.6%) and 1,453 (30.4%) were SARS-CoV-2 PCR test positive and never-infected, respectively. We found that patients with SARS-CoV-2 infection were more likely to have a loss of taste or smell [odds ratio (OR) 4.55, 95% confidence interval (CI) 1.93, 10.71], hair loss (OR 3.19, 95% CI 1.67, 6.09), neurocognitive symptoms (OR 1.95, 95% CI 1.43, 2.65), and respiratory symptoms (OR 1.23, 95% CI 1.03, 1.47) than never-infected patients. SARS-CoV-2 infection was not associated with common cold symptoms, chronic physical distress, or diarrhea as sequelae symptoms. Further, SARS-CoV-2 vaccination showed protective effects on sequelae of loss of taste or smell and hair loss.

Conclusions:

Loss of taste or smell, hair loss, neurocognitive symptoms, and respiratory symptoms were found to be specific sequelae of the SARS-CoV-2 Omicron variant. It is important not to miss these symptoms that follow SARS-CoV-2 infection and to recognize and manage the long COVID.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article